The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.
Remember this is a paid for POC, so an extension means we are gaining more time to integrate with "editing software of a major US technology player" As far as I am concerned, the more time spent integrating with a leading product like that, the better. And what's more we are gaining income from what would be an expensive development project. We are also gaining a route into a leading editing software package. My bet is we will probably become the leading cloud interface for that software ie an essential component. The prime minister came out with a surprise yesterday. If the PM can do it, so can others.
Koovs seems to be far bigger than I first thought. If you have a LinkedIn in account, it's worth logging in (or even getting an account) and doing a search for Koovs. LinkedIn reports 278 employees, I'm not sure how accurate that figure is, but one thing for sure, is that you will note the quality of the staff employed is very high.
Companies House info is all in the public domain now. A good source of information. Koovs PLC entry hTTps://beta.companieshouse.gov.uk/company/08166410/filing-history I have also researched some of the Koovs staff on LinkedIn. Not all, as there are 278 employees listed on LinkedIn !!! Koovs is far bigger than I thought! You will need a LinkedIn account to gain access. https://www.linkedin.com/vsearch/p?f_CC=802918&trk=extra_biz_employees_deg_connected What an amazing bunch of very talented people working at Koovs. This insight has really boosted my confidence in the company. GLA
Also, as mentioned on other board yesterday, we are bouncing of the fibonacci The rising trend channel looks narrow an steep and if the overhang is now clear, then this could move up fast. IMHO, DYOR
" It prefers to hold a controlling interest in all principal subsidiaries. NetScientific plc is based in London, United Kingdom." www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=35273274
Yep, up and down with the traders, but I think there will be a gradual rise as more of the stock is held for the longterm.
Afternoon should be fun, maybe a bit like yesterday. Note we have already exceeded yesterdays volume
14.85% may seem small, but that amount was marked down as US$1,657,030 on the 15 Dec 2014 so PDS value then $11,158,451 PDS, if listed on the Nasdaq, would be nearer $600m, we are miles away from that level.
Ernst & Young "The nominations are in. The Entrepreneur Of The Year Call for Nominations is now closed and we are excited to announce that we have received over 1400 entries from some of the countries most well deserving entrepreneurs. Stay tuned to learn more about our nominees and who will be named finalists this Spring and Award Winners this June." "2015 finalists announced Congratulations to the 2015 finalists for the EY Entrepreneur Of The Year Awards in New Jersey. Frank Bedu-Addo - PDS Biotechnology Corporation" www.ey.com/US/en/About-us/Entrepreneurship/Entrepreneur-Of-The-Year/NJ_Article_Regional_Finalists
oops that link did not work, again Nice Patent portfolio worldwide.espacenet.com/searchResults?submitted=true&locale=en_EP&DB=EPODOC&ST=advanced&TI=&AB=&PN=&AP=&PR=&PD=&PA=PDS+Biotechnology&IN=&CPC=&IC=&Submit=Search
Patents Nice Patent portfolio www.worldwide.espacenet.com/searchResults?submitted=true&locale=en_EP&DB=EPODOC&ST=advanced&TI=&AB=&PN=&AP=&PR=&PD=&PA=PDS+Biotechnology&IN=&CPC=&IC=&Submit=Search
I agree, I purchased on the news, then purchased mid afternoon, then just before close. I knew nothing about this company, but the more I look into their portfolio the more I like. I also like the fact this is still off the radar!
Science first, but still an impressive Board of Directors www.pdsbiotech.com/board_of_directors.html
For those who want to do some research see links below: - Link to PDS Biotechnology page hTtp://www.pdsbiotech.com/ "PDS Biotechnology today announced that the company has obtained an exclusive license from Merck Eprova AG to utilize Merck Eprova's proprietary chiral lipid DOTAP Chloride in Versamune(TM)-HPV and other products in development based on the Versamune(TM) technology." www.investegate.co.uk/pds-biotechnology/prn/pds-biotechnology-corporation-finalizes-commerc---/20090224165800NA597/ Like it www.pdsbiotech.com/products4.html
Just came across this recent scientific abstract from Toyota/Ilika "Tailor Made Electrolyte/Cathode Interfacial Buffer Layers for 5V-Class All-Solid-State Lithium Batteries" "Using this approach we have optimised the chemical compositions and crystallinity of ternary oxides and identified a new buffer layer material for this application" above quoted from htTp://myprogram14.ise-online.org/infiles/pdf/ise140680.pdf ALSO we had a US patent filed today (that was 5 minutes ago)!! GREAT NEWS "Vapour deposition process for the preparation of a phosphate compound" http://www.freshpatents.com/-dt20140925ptan20140287160.php
Will try link again http://www.worldwide.espacenet.com/searchResults?compact=false&ST=singleline&query=ILIKA+TECHNOLOGIES&locale=en_EP&DB=worldwide.espacenet.com
Some of theiir patents htTp://worldwide.espacenet.com/searchResults?compact=false&ST=singleline&query=ILIKA+TECHNOLOGIES&locale=en_EP&DB=worldwide.espacenet.com Patents are normally watertight. The risk is having the money to defend against any infringement, but that's the same for all patent holders.